UCL logo

UCL Discovery

UCL home » Library Services » Electronic resources » UCL Discovery

Randomized clinical trial: a pilot study investigating the safety and effectiveness of an escalating dose of peginterferon α-2a monotherapy for 48 weeks compared with standard clinical care in patients with hepatitis C cirrhosis.

Tanwar, S; Wright, M; Foster, GR; Ryder, SD; Mills, PR; Cramp, ME; ... Rosenberg, WM; + view all (2012) Randomized clinical trial: a pilot study investigating the safety and effectiveness of an escalating dose of peginterferon α-2a monotherapy for 48 weeks compared with standard clinical care in patients with hepatitis C cirrhosis. Eur J Gastroenterol Hepatol , 24 (5) 543 - 550. 10.1097/MEG.0b013e3283513e69.

Full text not available from this repository.

Abstract

A substantial proportion of patients with chronic hepatitis C virus (HCV) cirrhosis fail to eradicate infection and develop liver-related complications. Despite evidence that interferon-α has an antifibrotic effect, clinical trials have demonstrated that low-dose maintenance interferon does not improve outcomes in patients with compensated HCV cirrhosis following a lead-in phase of interferon. In a pilot study, we have investigated the efficacy of an escalating dose of pegylated interferon α-2a (PEG-IFN2a) as compared with standard clinical care in patients with more advanced HCV Child's A or B cirrhosis without a lead-in phase.

Type:Article
Title:Randomized clinical trial: a pilot study investigating the safety and effectiveness of an escalating dose of peginterferon α-2a monotherapy for 48 weeks compared with standard clinical care in patients with hepatitis C cirrhosis.
Location:England
DOI:10.1097/MEG.0b013e3283513e69
Language:English
Keywords:Adult, Antiviral Agents, Biological Markers, Dose-Response Relationship, Drug, Female, Hepatitis C, Chronic, Humans, Interferon-alpha, Kaplan-Meier Estimate, Liver Cirrhosis, Male, Middle Aged, Pilot Projects, Polyethylene Glycols, Prospective Studies, Quality of Life, Recombinant Proteins, Treatment Outcome

Archive Staff Only: edit this record